The third trimester is the “critical window” for risk, according to a study by coauthor Emily Barrett, an associate professor at Rutgers School of Public Health and the Environmental and Occupational Health Sciences Institute. To read more.
A Rutgers-led team has created better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer’s and Parkinson’s diseases and other neurological disorders. To read more.
The RCSB Protein Data Bank headquartered at Rutgers-New Brunswick has been awarded $34.5 million in grants over five years from three U.S. government agencies. Learn how this funding will support research at Rutgers and beyond.
The new Rutgers REACH hub will identify innovative health-related technologies by using the expertise of the National Cancer Institute-funded Rutgers Cancer Institute, RITMS, and the New Jersey Center for Biomaterials (NJCBM). These technologies will be evaluated for...